Ultragenyx Pharmaceutical, Inc. (RARE)
14.30
-0.10
(-0.69%)
USD |
NASDAQ |
Sep 11, 16:00
14.30
0.00 (0.00%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Price : 14.30 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 14.43 | 14.70 | 14.13 | 14.30 | 3.254M |
| Sep 10, 2026 | 14.25 | 14.44 | 13.95 | 14.40 | 3.665M |
| Sep 09, 2026 | 14.77 | 15.19 | 14.27 | 14.31 | 4.577M |
| Sep 08, 2026 | 15.10 | 15.25 | 14.63 | 14.88 | 5.926M |
| Sep 04, 2026 | 15.48 | 16.08 | 15.23 | 15.30 | 11.49M |
| Sep 03, 2026 | 14.00 | 15.00 | 13.81 | 14.85 | 27.16M |
| Sep 02, 2026 | 25.96 | 26.80 | 25.57 | 26.53 | 7.171M |
| Sep 01, 2026 | 25.22 | 25.85 | 25.10 | 25.81 | 1.872M |
| Aug 31, 2026 | 25.45 | 25.90 | 24.73 | 25.21 | 1.934M |
| Aug 28, 2026 | 26.54 | 26.73 | 25.37 | 25.61 | 1.613M |
| Aug 27, 2026 | 26.38 | 26.56 | 25.83 | 26.26 | 1.143M |
| Aug 26, 2026 | 26.54 | 26.66 | 25.61 | 26.44 | 1.668M |
| Aug 25, 2026 | 26.25 | 26.92 | 26.00 | 26.46 | 3.808M |
| Aug 24, 2026 | 25.75 | 26.09 | 25.30 | 25.72 | 1.537M |
| Aug 21, 2026 | 25.76 | 26.75 | 25.69 | 25.83 | 2.397M |
| Aug 20, 2026 | 28.39 | 28.50 | 25.04 | 25.32 | 3.841M |
| Aug 19, 2026 | 26.28 | 26.68 | 26.00 | 26.24 | 2.847M |
| Aug 18, 2026 | 25.68 | 26.11 | 24.97 | 25.49 | 1.793M |
| Aug 17, 2026 | 26.26 | 26.51 | 25.81 | 26.13 | 1.316M |
| Aug 14, 2026 | 26.30 | 26.58 | 25.75 | 26.49 | 1.222M |
| Aug 13, 2026 | 27.07 | 27.17 | 26.33 | 26.38 | 946128.0 |
| Aug 12, 2026 | 26.79 | 27.16 | 26.11 | 26.86 | 1.545M |
| Aug 11, 2026 | 27.16 | 27.59 | 26.42 | 26.96 | 2.139M |
| Aug 10, 2026 | 25.91 | 27.11 | 25.51 | 26.80 | 2.365M |
| Aug 07, 2026 | 26.34 | 26.71 | 25.30 | 25.91 | 3.829M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 257.12 |
| Biogen, Inc. | 217.15 |
| BioMarin Pharmaceutical, Inc. | 65.68 |
| Ionis Pharmaceuticals, Inc. | 54.21 |
| Regeneron Pharmaceuticals, Inc. | 781.49 |
Price Related Metrics
| PS Ratio | 2.005 |
| PEG Ratio | -0.4328 |
| Earnings Yield | -40.85% |
| Market Cap | 1.406B |
| PEGY Ratio | -0.4328 |